Ignite Creation Date:
2024-05-05 @ 5:35 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00489970
Status:
COMPLETED
Last Update Posted:
2020-05-01
First Post:
2007-06-21
Brief Title:
Persistence Study of GSK Biologicals Tdap Vaccine 1 3 5 and 9 Years Following Administration as an Initial Single Dose in Healthy Young Adults and to Evaluate the Immunogenicity and Safety of Boostrix as a Second Dose of Tdap When Administered at Year 9
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-06-01
Start Date Type:
ACTUAL
Primary Completion Date:
2011-09-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-03-01
Completion Date Type:
ACTUAL
First Submit Date:
2007-06-21
First Submit QC Date:
June 21 2007
Study First Post Date:
2007-06-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2010-08-11
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-04-21
Last Update Post Date:
2020-05-01
Last Update Post Date Type:
ACTUAL